Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5701491 | Journal of Thoracic Oncology | 2017 | 27 Pages |
Abstract
Our findings highlight CDCA3 as a prognostic factor and potential novel therapeutic target in NSCLC through inhibition of tumor growth and promotion of tumor senescence.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mark N. PhD, Joshua T. PhD, Yaowu PhD, Kathy PhD, Cameron PhD, Shu-Dong PhD, John D. PhD, Derek J. PhD, Kenneth J. MD,